A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion.
Ohmann HA, Kuper N, Wacker J (2020)
Personality neuroscience 3(e7).
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Ohmann, Hanno Andreas;
Kuper, NiclasUniBi;
Wacker, Jan
Abstract / Bemerkung
Dopamine (DA) is known to be involved in various aspects of reward processing and goal-directed behavior. The present preregistered study aims at directly accessing the causal influence of DA activity on reward motivation in humans, while also accounting for trait extraversion. Therefore, we examined the effect of a single dose of the DA D2 receptor antagonist sulpiride (200 mg) on effort allocation in a modified version of the Effort-Expenditure for Reward Task (EEfRT). Based on its presumably DA increasing action, we expected the low dose of sulpiride to increase participants' willingness to allocate effort during the modified EEfRT relative to placebo, especially in trials with low probability of reward attainment. Further, we expected a moderating effect of trait extraversion on the effects of sulpiride. Two hundred and three healthy male participants were tested in a randomized, double-blind between-subjects design. Contrary to our expectations, sulpiride reduced the average number of clicks within the modified EEfRT and did not interact with reward attributes, suggesting a more global and not reward-specific effect of sulpiride. Furthermore, trait extraversion did not moderate the effect of sulpiride. Our results provide initial support for the validity of the modified version of the EEfRT, suggesting a possible inhibiting effect of a low dose of sulpiride on approach motivation regardless of trait extraversion. However, given the mixed pattern of findings and the possible confounding role of motoric abilities, further studies examining these effects are clearly warranted. © The Author(s) 2020.
Erscheinungsjahr
2020
Zeitschriftentitel
Personality neuroscience
Band
3
Ausgabe
e7
eISSN
2513-9886
Page URI
https://pub.uni-bielefeld.de/record/2945005
Zitieren
Ohmann HA, Kuper N, Wacker J. A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion. Personality neuroscience. 2020;3(e7).
Ohmann, H. A., Kuper, N., & Wacker, J. (2020). A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion. Personality neuroscience, 3(e7). doi:10.1017/pen.2020.7
Ohmann, Hanno Andreas, Kuper, Niclas, and Wacker, Jan. 2020. “A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion.”. Personality neuroscience 3 (e7).
Ohmann, H. A., Kuper, N., and Wacker, J. (2020). A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion. Personality neuroscience 3.
Ohmann, H.A., Kuper, N., & Wacker, J., 2020. A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion. Personality neuroscience, 3(e7).
H.A. Ohmann, N. Kuper, and J. Wacker, “A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion.”, Personality neuroscience, vol. 3, 2020.
Ohmann, H.A., Kuper, N., Wacker, J.: A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion. Personality neuroscience. 3, (2020).
Ohmann, Hanno Andreas, Kuper, Niclas, and Wacker, Jan. “A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion.”. Personality neuroscience 3.e7 (2020).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Quellen
PMID: 32656492
PubMed | Europe PMC
Suchen in